The Concomitant Use of Melatonin and Molnupiravir in the Treatment of COVID-19: Mini Review

Authors

  • Ismail Celil Haskologlu Department of Pharmacology, Faculty of Pharmacy, Near East University, Nicosia, Cyprus
  • Emine Erdag Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Near East University, Nicosia, Cyprus
  • Serkan Sayiner Department of Biochemistry, Faculty of Veterinary Medicineand Diagnostic Laboratory, Animal Hospital, Near East University, Nicosia, Cyprus
  • Merve Mercan Department of Pharmacology, Faculty of Pharmacy, Near East University, Nicosia, Cyprus
  • Ugochukwu Chukwunyere Department of Pharmacology, Faculty of Pharmacy, Near East University, Nicosia, Cyprus
  • Nurettin Abacioglu Department of Pharmacology, Faculty of Pharmacy, Near East University, Nicosia, Cyprus
  • Ahmet Ozer Sehirli Department of Pharmacology, Faculty of Dentistry, Near East University, Nicosia, Cyprus.

DOI:

https://doi.org/10.3329/bjms.v22i1.61857

Keywords:

Molnupiravir; melatonin; cytokine; SARS-CoV-2; COVID-19

Abstract

With the ongoing pandemic declared by the World Health Organization,the number of hospitalizations and deaths caused by COVID-19 is increasing dramatically. As new variants of SARS-CoV-2 emerge, new combination therapies are needed to reduce the risk of COVID- 19spreadduring this time of increased transmission risk. In this case, it is vitalto strengthen the immune system against highly inflammatory conditions such as the cytokine storm caused by COVID-19. This brief review highlights the benefits of taking melatonin and the new antiviral drug molnupiravir together in the treatment of COVID-19. Webelieve that this combination therapy against COVID-19 would be of great benefit and should be considered as an adjuvant therapy in the treatment of this disease.

Bangladesh Journal of Medical Science Vol. 22 No. 01 January’23 Page : 32-37

Downloads

Download data is not yet available.
Abstract
283
PDF
344

Downloads

Published

2023-01-01

How to Cite

Haskologlu, I. C. ., Erdag, E. ., Sayiner, S. ., Mercan, M., Chukwunyere, U. ., Abacioglu, N. ., & Sehirli, A. O. (2023). The Concomitant Use of Melatonin and Molnupiravir in the Treatment of COVID-19: Mini Review. Bangladesh Journal of Medical Science, 22(1), 32–37. https://doi.org/10.3329/bjms.v22i1.61857

Issue

Vol. 22 No. 1 (2023)

Section

Review Article

License

Copyright (c) 2022 Ismail Celil Haskologlu, Emine Erdag, Serkan Sayiner, Merve Mercan, Ugochukwu Chukwunyere, Nurettin Abacioglu, Ahmet Ozer Sehirli

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

Authors who publish in the Bangladesh Journal of Medical Science agree to the following terms that:

  1. Authors retain copyright and grant Bangladesh Journal of Medical Science the right of first publication of the work.

  2. Creative Commons Licence
    Articles in Bangladesh Journal of Medical Science are licensed under a Creative Commons Attribution 4.0 International License CC BY-4.0.This license permits use, distribution and reproduction in any medium, provided the original work is properly cited.
  3. Authors are able to enter into separate, additional contractual arrangements for the distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
  4. Authors are permitted to post their work online (e.g., in institutional repositories or on their website) as it can lead to productive exchanges, as well as greater citation of published work.